Insights Gained From the <scp>PPMI</scp> Brain Donation Program
Brain autopsy plays a critical role advancing understanding of neurological conditions, providing unique insights that may otherwise not be captured through studies of living individuals. In addition, given our increasing reliance on biomarkers of disease biology, pathology is the gold standard to validate biomarkers showing that early evidence of disease biology is consistent with postmortem pathology. Postmortem tissue collection is challenging, and opportunities to correlate neuropathological findings with longitudinal clinical, genetic, imaging, and biomarker data are often limited. The Parkinson's Progression Markers Initiative study demonstrates how centralized brain donation leads to a higher number of successful tissue collections. Summarized findings from study cases highlight how neuropathology enhances disease characterization and how plans to implement new and innovative methods for neuropathological analysis will advance the field. ANN NEUROL 2026.
Authors
- Kathleen L. Poston (ORCID: https://orcid.org/0000-0003-3424-7143)
- Malia Rumbaugh
- Gena Antonopoulos
- Christine L. Mac Donald
- C. Dirk Keene
- Tom Montine
- Laura E. A. Heathers
- Kenneth Marek
- the Parkinson's Progression Markers Initiative
- Caitlin S. Latimer
- Kumar Mantravadi
- Tatiana Foroud
- Syed Bukhari
- Thomas F. Tropea
Institutions
- Palo Alto University (US)
- University of Washington (US)
- Institute for Neurodegenerative Disorders (US)
- Indiana University School of Medicine
- Indiana University – Purdue University Indianapolis (US)
- University of Pennsylvania (US)
- Stanford University (US)
Publication Details
- Journal
- Annals of Neurology
- Published
- 2026-04-26
- DOI
- https://doi.org/10.1002/ana.78229
- Primary Topic
- Organ Donation and Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00